Activity of five fluoroquinolones against Mycobacterium avium-intracellulare complex and M. xenopi.
Rastogi
N
N
Unité de la Tuberculose et des Mycobactéries, Institut Pasteur, Paris.
Goh
K S
KS
David
H L
HL
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002939:Ciprofloxacin / Q000494:pharmacology; D015365:Enoxacin; D009161:Mycobacterium / Q000187:drug effects*; D009162:Mycobacterium avium / Q000187:drug effects*; D009287:Naphthyridines / Q000494:pharmacology; D009170:Nontuberculous Mycobacteria / Q000187:drug effects*; D009643:Norfloxacin / Q000031:analogs & derivatives / Q000494:pharmacology; D015242:Ofloxacin; D010078:Oxazines / Q000494:pharmacology; D015366:Pefloxacin
D000900:Anti-Bacterial Agents; D009287:Naphthyridines; D010078:Oxazines; D015366:Pefloxacin; D015365:Enoxacin; D002939:Ciprofloxacin; D015242:Ofloxacin; D009643:Norfloxacin